(Q43121941)

English

Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs

scientific article published on 19 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1 reference

based on heuristic

inferred from title

author name string

Koichi Kawamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Anil Pahuja

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Bernhard J Hering

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Pratima Bansal-Pakala

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Transplant Immunology

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

28-33

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

International trial of the Edmonton protocol for islet transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Five-year follow-up after clinical islet transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Recovery from diabetes in mice by beta cell regeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

TGF-beta: a master of all T cell trades

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Smad-dependent cooperative regulation of interleukin 2 receptor alpha chain gene expression by T cell receptor and transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

TOR signaling in growth and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Rapamycin Has a Deleterious Effect on MIN-6 Cells and Rat and Human Islets

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Effects of histone deacetylase inhibitor SAHA on effector and FOXP3+regulatory T cells in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

TGF-beta 1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Immunoregulatory functions of mTOR inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.03.004

7 January 2021

Identifiers

10.1016/J.TRIM.2010.03.004

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43121941&oldid=1981315124"